Changes in Sensitivity and Specificity of Transient Ischemic Dilation for Severe and Extensive CAD With or Without LVH or Diabetes
| Variable | Sensitivity | Specificity |
|---|---|---|
| Overall | 30% (14/46) | 93% (54/57) |
| LVH | 75% (6/8) | 80% (9/11) |
| No LVH | 21% (8/38) | 95% (44/46) |
| Diabetic | 61% (8/13) | 70% (7/10) |
| Nondiabetic | 21% (7/33) | 98% (46/47) |